Litcius/Paper detail

Predictors of Survival Benefit From Immune Checkpoint Inhibitors in Patients With Advanced Non–small-cell Lung Cancer: A Systematic Review and Meta-analysis

Jacques Raphael, Anupam Batra, Gabriel Boldt, Prakesh S. Shah, Phillip Blanchette, George Rodrigues, Mark Vincent

2020Clinical Lung Cancer27 citationsDOI

Topics & Concepts

MedicineMeta-analysisLung cancerOncologyNivolumabInternal medicineImmune systemCancerImmunotherapyImmunologyCancer Immunotherapy and BiomarkersLung Cancer Treatments and MutationsLung Cancer Research Studies
Predictors of Survival Benefit From Immune Checkpoint Inhibitors in Patients With Advanced Non–small-cell Lung Cancer: A Systematic Review and Meta-analysis | Litcius